Table IV.
Association between the mRNA expression of miR-196 and HoxB8 and the clinicopathological features of colorectal cancer.
Clinicopathological characteristics | n | Expression of miR-196 mRNA | Z-value | P-value | Expression of HoxB8 mRNA | Z-value | P-value |
---|---|---|---|---|---|---|---|
Gender | −0.968 | 0.333 | −0.667 | 0.505 | |||
Male | 19 | 1.551±1.100 | 1.767±1.237 | ||||
Female | 11 | 2.090±1.311 | 1.403±0.733 | ||||
Age | −1.348 | 0.178 | −1.597 | 0.110 | |||
>60 years | 15 | 1.412±1.000 | 1.879±1.205 | ||||
≤60 years | 15 | 2.085±1.298 | 1.388±0.914 | ||||
Tumor diameter, cm | −0.396 | 0.692 | −0.352 | 0.725 | |||
>4 | 10 | 1.889±1.195 | 1.810±1.206 | ||||
≤4 | 20 | 1.678±1.210 | 1.545±1.033 | ||||
Macroscopic type of tumora | 2.479b | 0.290 | 2.516b | 0.284 | |||
Ulcerative | 18 | 1.658±1.183 | 1.782±1.175 | ||||
Protrusive | 8 | 1.489±1.151 | 1.658±1.036 | ||||
Infiltrative | 4 | 2.634±1.167 | 0.915±0.347 | ||||
Tissue differentiationa | 0.973b | 0.615 | 0.410b | 0.815 | |||
High | 1 | 0.704±0.000 | 1.202±0.000 | ||||
Moderate | 28 | 1.792±1.214 | 1.674±1.107 | ||||
Low | 1 | 1.595±0.000 | 0.942±0.000 | ||||
Tumor staging | −2.948 | 0.003 | −1.276 | 0.202 | |||
I+II | 10 | 0.847±0.349 | 1.854±1.071 | ||||
III+IV | 20 | 2.199±1.207 | 1.523±1.095 | ||||
Depth of invasion | −0.610 | 0.542 | −0.516 | 0.606 | |||
T1+T2 | 8 | 1.635±1.391 | 1.454±0.914 | ||||
T3+T4 | 22 | 1.790±1.140 | 1.699±1.147 | ||||
Tumor location | −0.125 | 0.901 | −0.333 | 0.739 | |||
Rectum | 16 | 1.696±1.133 | 1.609±0.882 | ||||
Colon | 14 | 1.809±1.290 | 1.661±1.305 | ||||
Lymph node metastasis | −2.921 | 0.003 | −1.482 | 0.138 | |||
Yes | 18 | 2.245±1.153 | 1.504±1.132 | ||||
No | 12 | 1.005±0.816 | 1.827±1.012 | ||||
Distant metastasis | −2.800 | 0.005 | −0.726 | 0.468 | |||
Yes | 3 | 4.146±0.758 | 1.220±0.840 | ||||
No | 27 | 1.482±0.892 | 1.679±1.107 |
Kruskal Wallis H test
χ2. Data are expressed as the mean ± standard deviation. miR, micro RNA; mRNA, messenger RNA; Hox, homeobox; miR, microRNA.